Grand Pharmaceutical Group (SEHK:512) Balance Sheet Analysis 2004-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Cash And Short-Term Investments	HK$2.474B	HK$3.141B	HK$1.81B
Net Receivables	HK$2.25B	HK$2.786B	HK$3.977B
Inventory	HK$1.389B	HK$1.371B	HK$1.417B
Prepaid Expenses And Other Current Assets	HK$796.381M	HK$591.333M	-
Other Current Assets	HK$106.454M	HK$136.237M	HK$818.538M
Total Current Assets	HK$7.016B	HK$8.026B	HK$8.022B
Property, Plant And Equipment	HK$3.986B	HK$3.836B	HK$4.427B
Goodwill And Intangible Assets	HK$2.246B	HK$3.813B	HK$4.537B
Long-Term Investments	HK$8.398B	HK$6.239B	HK$8.094B
Deferred Tax Assets	HK$25.111M	HK$33.456M	-
Other Noncurrent Assets	HK$0.845B	HK$3.045B	HK$1.387B
Total Noncurrent Assets	HK$15.499B	HK$16.966B	HK$18.445B
Other Assets	-	-	-
Total Assets	HK$22.515B	HK$24.991B	HK$26.467B

Metric	2023	2024	LTM
Total Payables	HK$1.662B	HK$1.459B	HK$1.897B
Accrued Expenses	-	-	HK$1.976B
Short-Term Debt	HK$2.318B	HK$3.127B	HK$2.777B
Current Portion Of Lease Obligations	HK$34.611M	HK$18.315M	HK$9.502M
Income Taxes Payable	HK$332.063M	HK$338.487M	-
Current Deferred Revenue	HK$198.173M	-	-
Other Current Liabilities	HK$1.518B	HK$1.969B	HK$0.312B
Total Current Liabilities	HK$5.731B	HK$6.573B	HK$6.691B
Long-Term Debt	HK$0.928B	HK$1.216B	HK$1.753B
Capital Lease Obligations	HK$96.225M	HK$58.919M	HK$46.851M
Noncurrent Deferred Revenue	HK$240.105M	HK$295.369M	HK$308.653M
Noncurrent Deferred Tax Liabilities	HK$221.626M	HK$300.351M	HK$349.37M
Other Noncurrent Liabilities	-	-	-
Total Noncurrent Liabilities	HK$1.513B	HK$1.893B	HK$2.486B
Other Liabilities	-	-	-
Total Liabilities	HK$7.245B	HK$8.466B	HK$9.177B

Metric	2023	2024	LTM
Treasury Stock	HK$-268.503M	HK$-268.503M	HK$-268.503M
Preferred Stock	HK$121.825M	-	-
Common Stock	HK$35.496M	HK$35.496M	HK$35.496M
Retained Earnings	HK$8.868B	HK$10.304B	HK$11.383B
Additional Paid-In Capital	HK$6.644B	HK$6.644B	HK$6.644B
Accumulated Other Comprehensive Income	HK$-121.825M	HK$-242.266M	HK$-640.958M
Other Stockholders' Equity	HK$-121.825M	-	-
Total Common Stockholders' Equity	HK$15.158B	HK$16.473B	HK$17.154B
Minority Interest	HK$112.798M	HK$52.128M	HK$136.798M
Total Equity	HK$15.271B	HK$16.525B	HK$17.291B
Total Liabilities And Equity	HK$22.515B	HK$24.991B	HK$26.467B

Metric	2023	2024	LTM
Total Investments	HK$9.532B	HK$8.039B	HK$8.626B
Total Debt	HK$3.404B	HK$4.443B	HK$4.614B
Net Debt	HK$2.065B	HK$3.102B	HK$4.135B

Grand Pharmaceutical Group
512

Balance Sheet

Balance Sheet Composition

Grand Pharmaceutical Group 512

Balance Sheet

Balance Sheet Composition

Grand Pharmaceutical Group
512